Lexaria Bioscience Corp. Announces $3.5M Direct Offering with Nasdaq Rules
Update: 2025-12-15
Description
Lexaria Bioscience Corp. is conducting a registered direct offering priced At-the-Market under Nasdaq Rules, involving the sale of 2,661,600 shares of common stock at $1.315 per share. The Company will also issue unregistered warrants for additional shares. The proceeds will be used for research, development, working capital, and corporate purposes, with the closing expected on December 16, 2025. H.C. Wainwright &Co. is the exclusive placement agent for the offering.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
